000 01386 a2200373 4500
005 20250515051356.0
264 0 _c20070201
008 200702s 0 0 eng d
022 _a0927-3948
024 7 _a10.1080/09273940600976953
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOzdek, Sengul C
245 0 0 _aIn vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections.
_h[electronic resource]
260 _bOcular immunology and inflammation
_cDec 2006
300 _a347-51 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Infective Agents
_xpharmacology
650 0 4 _aAza Compounds
_xpharmacology
650 0 4 _aCandida
_xdrug effects
650 0 4 _aColony Count, Microbial
650 0 4 _aEye Infections, Fungal
_xmicrobiology
650 0 4 _aFluoroquinolones
_xpharmacology
650 0 4 _aGatifloxacin
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aMoxifloxacin
650 0 4 _aQuinolines
_xpharmacology
650 0 4 _aRetrospective Studies
700 1 _aMiller, Darlene
700 1 _aFlynn, Patrick M
700 1 _aFlynn, Harry W
773 0 _tOcular immunology and inflammation
_gvol. 14
_gno. 6
_gp. 347-51
856 4 0 _uhttps://doi.org/10.1080/09273940600976953
_zAvailable from publisher's website
999 _c16731205
_d16731205